FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140375321> ?p ?o ?g. }

• W2140375321 endingPage "486" @default.
• W2140375321 startingPage "477" @default.
• W2140375321 abstract "Farnesyl protein transferase inhibitors (FTIs) have demonstrated clinical activity in certain solid tumors and hematological malignancies. Little is known about mechanisms of resistance to these agents. To provide a basis for better understanding FTI resistance, the colorectal carcinoma cell line HCT 116 was selected by stepwise exposure to increasing 4-(2-(4-(8-chloro-3,10-dibromo-6,11-dihydro-5<i>H</i>-benzo-(5,6)-cyclohepta(1,2-<i>b</i>)-pyridin-11(<i>R</i>)-yl)-1-piperidinyl)-2-oxo-ethyl)-1-piperidinecarboxamide (SCH66336) concentrations. The resulting line, HCT 116R, was 100-fold resistant to SCH66336 and other FTIs, including methyl {<i>N</i>-[2-phenyl-4-<i>N</i>[2(<i>R</i>)-amino-3-mercaptopropylamino] benzoyl]}-methionate (FTI-277), but was less than 2-fold resistant to the standard agents gemcitabine, cisplatin, and paclitaxel. Accumulation of the unfarnesylated forms of prelamin A and HDJ-2, two substrates that reflect farnesyl transferase inhibition, was similar in FTI-treated parental and HCT 116R cells, indicating that alterations in drug uptake or inhibition of farnesyl protein transferase is not the mechanism of resistance. Changes in signal-transduction pathways that might account for this resistance were examined by immunoblotting and confirmed pharmacologically. There was no difference in activation of the mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase pathway or sensitivity to the MEK1/2 inhibitor 2′-amino-3′-methoxyflavone (PD98059) in HCT 116R cells. In contrast, increased phosphorylation of the molecular target of rapamycin (mTOR) and its downstream target p70 S6 kinase and increased levels of Akt1 and Akt2 were demonstrated in HCT 116R cells. Further experiments demonstrated that the mTOR inhibitor rapamycin selectively sensitized HCT 116R cells to SCH66336 but not to gemcitabine, cisplatin, or paclitaxel. These findings provide evidence that alterations in the phosphatidylinositol-3 kinase/Akt pathway can contribute to FTI resistance and suggest a potential strategy for overcoming this resistance." @default.
• W2140375321 created "2016-06-24" @default.
• W2140375321 creator A5041114807 @default.
• W2140375321 creator A5051650281 @default.
• W2140375321 creator A5054370710 @default.
• W2140375321 creator A5062825028 @default.
• W2140375321 date "2005-05-18" @default.
• W2140375321 modified "2023-09-25" @default.
• W2140375321 title "Characterization of a Human Carcinoma Cell Line Selected for Resistance to the Farnesyl Transferase Inhibitor 4-(2-(4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo-(5,6)-cyclohepta(1,2-b)-pyridin-11(R)-yl)-1-piperidinyl)-2-oxo-ethyl)-1-piperidinecarboxamide (SCH66336)" @default.
• W2140375321 cites W1484076261 @default.
• W2140375321 cites W1515462367 @default.
• W2140375321 cites W1873121398 @default.
• W2140375321 cites W1989203819 @default.
• W2140375321 cites W2015985237 @default.
• W2140375321 cites W2017018900 @default.
• W2140375321 cites W2017098460 @default.
• W2140375321 cites W2025771828 @default.
• W2140375321 cites W2035416139 @default.
• W2140375321 cites W2036082581 @default.
• W2140375321 cites W2036699032 @default.
• W2140375321 cites W2051538397 @default.
• W2140375321 cites W2059431360 @default.
• W2140375321 cites W2061234826 @default.
• W2140375321 cites W2079537922 @default.
• W2140375321 cites W2102648794 @default.
• W2140375321 cites W2102901804 @default.
• W2140375321 cites W21378047 @default.
• W2140375321 cites W2141916872 @default.
• W2140375321 cites W2147114673 @default.
• W2140375321 cites W2165254910 @default.
• W2140375321 cites W2176744910 @default.
• W2140375321 cites W2178557511 @default.
• W2140375321 cites W4213005885 @default.
• W2140375321 cites W4232534952 @default.
• W2140375321 cites W4293247451 @default.
• W2140375321 doi "https://doi.org/10.1124/mol.104.010074" @default.
• W2140375321 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15901852" @default.
• W2140375321 hasPublicationYear "2005" @default.
• W2140375321 type Work @default.
• W2140375321 sameAs 2140375321 @default.
• W2140375321 citedByCount "11" @default.
• W2140375321 countsByYear W21403753212012 @default.
• W2140375321 countsByYear W21403753212017 @default.
• W2140375321 crossrefType "journal-article" @default.
• W2140375321 hasAuthorship W2140375321A5041114807 @default.
• W2140375321 hasAuthorship W2140375321A5051650281 @default.
• W2140375321 hasAuthorship W2140375321A5054370710 @default.
• W2140375321 hasAuthorship W2140375321A5062825028 @default.
• W2140375321 hasConcept C104202773 @default.
• W2140375321 hasConcept C181199279 @default.
• W2140375321 hasConcept C184235292 @default.
• W2140375321 hasConcept C185592680 @default.
• W2140375321 hasConcept C2776376580 @default.
• W2140375321 hasConcept C55493867 @default.
• W2140375321 hasConcept C62478195 @default.
• W2140375321 hasConcept C75217442 @default.
• W2140375321 hasConcept C86803240 @default.
• W2140375321 hasConcept C97029542 @default.
• W2140375321 hasConcept C98274493 @default.
• W2140375321 hasConceptScore W2140375321C104202773 @default.
• W2140375321 hasConceptScore W2140375321C181199279 @default.
• W2140375321 hasConceptScore W2140375321C184235292 @default.
• W2140375321 hasConceptScore W2140375321C185592680 @default.
• W2140375321 hasConceptScore W2140375321C2776376580 @default.
• W2140375321 hasConceptScore W2140375321C55493867 @default.
• W2140375321 hasConceptScore W2140375321C62478195 @default.
• W2140375321 hasConceptScore W2140375321C75217442 @default.
• W2140375321 hasConceptScore W2140375321C86803240 @default.
• W2140375321 hasConceptScore W2140375321C97029542 @default.
• W2140375321 hasConceptScore W2140375321C98274493 @default.
• W2140375321 hasIssue "2" @default.
• W2140375321 hasLocation W21403753211 @default.
• W2140375321 hasLocation W21403753212 @default.
• W2140375321 hasOpenAccess W2140375321 @default.
• W2140375321 hasPrimaryLocation W21403753211 @default.
• W2140375321 hasRelatedWork W1990575044 @default.
• W2140375321 hasRelatedWork W2001208964 @default.
• W2140375321 hasRelatedWork W2068240886 @default.
• W2140375321 hasRelatedWork W2168882041 @default.
• W2140375321 hasRelatedWork W2350517500 @default.
• W2140375321 hasRelatedWork W2369110093 @default.
• W2140375321 hasRelatedWork W2748229641 @default.
• W2140375321 hasRelatedWork W2902957487 @default.
• W2140375321 hasRelatedWork W4254421120 @default.
• W2140375321 hasRelatedWork W908783801 @default.
• W2140375321 hasVolume "68" @default.
• W2140375321 isParatext "false" @default.
• W2140375321 isRetracted "false" @default.
• W2140375321 magId "2140375321" @default.
• W2140375321 workType "article" @default.